UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

(223) APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy

The journal of pain, 2017-04, Vol.18 (4), p.S31-S32

2017

Volltextzugriff (PDF)

Sunflower as a Potential Trap Crop of Halyomorpha halys (Hemiptera: Pentatomidae) in Pepper Fields

Environmental entomology, 2015-12, Vol.44 (6), p.1581-1589

2015

Volltextzugriff (PDF)

(435) Nausea and vomiting with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs morphine: an analysis of tolerability from a phase 2b randomized clinical trial

The journal of pain, 2016-04, Vol.17 (4), p.S83-S83

2016

Volltextzugriff (PDF)

(432) Respiratory safety signal with oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), vs morphine: a safety analysis of a Phase 2b randomized clinical trial

The journal of pain, 2016-04, Vol.17 (4), p.S82-S82

2016

Volltextzugriff (PDF)

(343) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. II: simulation of potential dosing regimens using a pharmacokinetic/pharmacodynamic (PK/PD) model

The journal of pain, 2016-04, Vol.17 (4), p.S61-S61

2016

Volltextzugriff (PDF)

(433) Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials

The journal of pain, 2016-04, Vol.17 (4), p.S82-S83

2016

Volltextzugriff (PDF)

(342) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. I: development of a pharmacokinetic/pharmacodynamic (PK/PD) model

The journal of pain, 2016-04, Vol.17 (4), p.S61-S61

2016

Volltextzugriff (PDF)

Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites

Circulation research, 2004-03, Vol.94 (4), p.496-504

2004

Volltextzugriff (PDF)

(478) TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers

The journal of pain, 2014-04, Vol.15 (4), p.S95-S95

2014

Volltextzugriff (PDF)

An orally available mu-opioid receptor biased ligand is analgesic with reduced constipation in rodents

The journal of pain, 2013-04, Vol.14 (4), p.S70-S70

2013

Volltextzugriff (PDF)

New perspectives for hypertension management: progress in methodological and technological developments

European journal of preventive cardiology, 2023-01, Vol.30 (1), p.48-60

2023

Volltextzugriff (PDF)

Automatic recognition of spontaneous speech for access to multilingual oral history archives

IEEE transactions on speech and audio processing, 2004-07, Vol.12 (4), p.420-435

2004

Volltextzugriff (PDF)

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain

Pain (Amsterdam), 2016-01, Vol.157 (1), p.264-272

2016

Volltextzugriff (PDF)

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

Journal of pain research, 2017-01, Vol.10, p.2413-2424

2017

Volltextzugriff (PDF)

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

Journal of pain research, 2019-01, Vol.12, p.927-943

2019

Volltextzugriff (PDF)

First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

Journal of clinical pharmacology, 2014-03, Vol.54 (3), p.351-357

2014

Volltextzugriff (PDF)

Coda-Q in the 2.5–20 s period band from seismic noise: application to the greater Alpine area

Geophysical journal international, 2020-01, Vol.220 (1), p.202-217

2020

Volltextzugriff (PDF)

First Clinical Experience with TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

Journal of clinical pharmacology, 2013-09, Vol.53 (9), p.892-899

2013

Volltextzugriff (PDF)

Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation

American journal of physiology. Heart and circulatory physiology, 2004-05, Vol.286 (5), p.H1785-H1792

2004

Volltextzugriff (PDF)

Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry

Molecular pharmacology, 1992-03, Vol.41 (3), p.487-493

1992

Volltextzugriff (PDF)

Maintained contractile reserve in a transgenic mouse model of myocardial stunning

American journal of physiology. Heart and circulatory physiology, 2001-06, Vol.280 (6), p.H2623-H2630

2001

Volltextzugriff (PDF)

Oliceridine, a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model

Journal of clinical pharmacology, 2018-06, Vol.58 (6), p.762-770

2018

Volltextzugriff (PDF)

A framework for digital library research: broadening the vision

D-Lib magazine, 2002-12, Vol.8 (12)

Soergel, D

2002

Volltextzugriff (PDF)

Predation on Zebra Mussels (Dreissena polymorpha) by Common Carp (Cyprinus carpio)

Journal of freshwater ecology, 1996-09, Vol.11 (3), p.363-372

1996

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(228)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(139)
Life Sciences & Biomedicine
(78)
Remote Sensing
(67)
Humans
(53)
Technology
(53)
Physical Sciences
(48)
Applied Geophysics
(41)
Male
(34)
Female
(28)
Biological And Medical Sciences
(26)
Data Processing
(26)
Adult
(25)
Imagery
(25)
Imaging Science & Photographic Technology
(25)
Geography, Physical
(24)
Middle Aged
(24)
Physical Geography
(24)
Animals
(23)
Asia
(23)
Medical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

(223) APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy

Sunflower as a Potential Trap Crop of Halyomorpha halys (Hemiptera: Pentatomidae) in Pepper Fields

(435) Nausea and vomiting with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs morphine: an analysis of tolerability from a phase 2b randomized clinical trial

(432) Respiratory safety signal with oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), vs morphine: a safety analysis of a Phase 2b randomized clinical trial

(343) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. II: simulation of potential dosing regimens using a pharmacokinetic/pharmacodynamic (PK/PD) model

(433) Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials

(342) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. I: development of a pharmacokinetic/pharmacodynamic (PK/PD) model

Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites

(478) TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers

An orally available mu-opioid receptor biased ligand is analgesic with reduced constipation in rodents

REMIND2.1: transformation and innovation dynamics of the energy-economic system within climate and sustainability limits

New perspectives for hypertension management: progress in methodological and technological developments

Automatic recognition of spontaneous speech for access to multilingual oral history archives

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

Coda-Q in the 2.5–20 s period band from seismic noise: application to the greater Alpine area

First Clinical Experience with TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation

Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry

Maintained contractile reserve in a transgenic mouse model of myocardial stunning

Oliceridine, a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model

A framework for digital library research: broadening the vision

Predation on Zebra Mussels (Dreissena polymorpha) by Common Carp (Cyprinus carpio)

Suchergebnisse filtern